Malgorzata (Gosia) A. Garstka, PhD
Affiliations: | Xi'an Jiaotong University, PR China |
Google:
"Malgorzata (Gosia) Garstka"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Garstka MA, Fish A, Celie PH, et al. (2015) The first step of peptide selection in antigen presentation by MHC class I molecules. Proceedings of the National Academy of Sciences of the United States of America. 112: 1505-10 |
| Garstka MA, Neefjes J. (2013) How to target MHC class II into the MIIC compartment Molecular Immunology. 55: 162-165 |
| Berlin I, Wijdeven R, Garstka M, et al. (2012) Deubiquitinating enzymes in control of MHC class-II transport Molecular Immunology. 51: 8-9 |
| Garstka MA, Fritzsche S, Lenart I, et al. (2011) Tapasin dependence of major histocompatibility complex class I molecules correlates with their conformational flexibility. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 25: 3989-98 |
| Horst D, Favaloro V, Vilardi F, et al. (2011) EBV protein BNLF2a exploits host tail-anchored protein integration machinery to inhibit TAP. Journal of Immunology (Baltimore, Md. : 1950). 186: 3594-605 |
| Howe C, Garstka M, Al-Balushi M, et al. (2009) Calreticulin-dependent recycling in the early secretory pathway mediates optimal peptide loading of MHC class I molecules. The Embo Journal. 28: 3730-44 |
| Palankar R, Skirtach AG, Kreft O, et al. (2009) Controlled intracellular release of peptides from microcapsules enhances antigen presentation on MHC class I molecules. Small (Weinheim An Der Bergstrasse, Germany). 5: 2168-76 |
| Schneeweiss C, Garstka M, Smith J, et al. (2009) The mechanism of action of tapasin in the peptide exchange on MHC class I molecules determined from kinetics simulation studies. Molecular Immunology. 46: 2054-63 |
| Horst D, van Leeuwen D, Croft NP, et al. (2009) Specific targeting of the EBV lytic phase protein BNLF2a to the transporter associated with antigen processing results in impairment of HLA class I-restricted antigen presentation. Journal of Immunology (Baltimore, Md. : 1950). 182: 2313-24 |
| Palankar R, Skirtach AG, Kreft O, et al. (2009) Intracellular transport: Small 19/2009 Small. 5: NA-NA |